Pyrrolyl thiadiazoles as Mycobacterium tuberculosis inhibitors and their in silico analyses

References

• Bogatcheva E, Hanrahan C, Nikonenko B, et al. Identification of new diamine scaffolds with activity against Mycobacterium tuberculosis. J Med Chem. 2006;49(11):3045–3048.
   Google Scholar
• Rattan A, Kalia A, Ahmad N. Multidrug-resistant Mycobacterium tuberculosis: molecular perspectives. Emerg Infect Dis. 1998;4(2):195–209.
   PubMed Web of Science ®Google Scholar
• Bloch K. Control mechanisms for fatty acid synthesis in Mycobacterium smegmatis. Adv Enzymol Relat Areas Mol Biol. 1977;45:1–84.
   PubMedGoogle Scholar
• Kikuchi S, Rainwater DL, Kolattukudy PE. Purification and characterization of an unusually large fatty acid synthase from Mycobacterium tuberculosis var. bovis BCG. Arch. Biochem Biophys. 1992;295(2):318–326.
   Web of Science ®Google Scholar
• Qureshi N, Sathyamoorthy N, Takayama K. Biosynthesis of C30 to C56 fatty acids by an extract of Mycobacterium tuberculosis H37Ra. J Bacteriol. 1984;157(1):46–52.
   Web of Science ®Google Scholar
• Brennan PJ, Nikaido H. The envelope of mycobacteria. Annu Rev Biochem. 1995;64(1):29–63.
   PubMedGoogle Scholar
• Lee RE, Brennan PJ, Besra GS. Mycobacterium tuberculosis cell envelope. Curr Top Microbiol Immunol. 1996;215:1–27.
   PubMed Web of Science ®Google Scholar
• Banerjee A, Dubnau E, Quemard A, et al. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science. 1994;263(5144):227–230.
   Google Scholar
• Wang F, Langley R, Gulten G, et al. Mechanism of thioamide drug action against tuberculosis and leprosy. J Exp Med. 2007;204(1):73–78.
   PubMed Web of Science ®Google Scholar
• Kuo MR, Morbidoni HR, Alland D, et al. Targeting tuberculosis and malaria through inhibition of Enoyl reductase: compound activity and structural data. J Biol Chem. 2003;278(23):20851–20859.
   PubMed Web of Science ®Google Scholar
• Sullivan TJ, Truglio JJ, Boyne ME, et al. High affinity InhA inhibitors with activity against drug-resistant strains of Mycobacterium tuberculosis. ACS Chem Biol. 2006;1(1):43–53.
   Web of Science ®Google Scholar
• He X, Alian A, Stroud R, Ortiz de Montellano PR. Pyrrolidine carboxamides as a novel class of inhibitors of enoyl acyl carrier protein reductase from Mycobacterium tuberculosis. J Med Chem. 2006;49(21):6308–6323.
   Google Scholar
• Joshi SD, More UA, Kulkarni VH, Aminabhavi TM. Pyrrole: chemical synthesis, microwave assisted synthesis, reactions and applications: A review. Curr Org Chem. 2013;17(20):2279–2304.
   Web of Science ®Google Scholar
• Bhat AR, Tazeem, Azam A, Choi I, Athar F. 3-(1,3,4-Thiadiazole-2-yl)quinoline derivatives: synthesis, characterization and anti-microbial activity. Eur J Med Chem. 2011;46(7):3158–3166.
   Web of Science ®Google Scholar
• Talath S, Gadad AK. Synthesis, antibacterial and antitubercular activities of some 7-[4-(5-amino-[1,3,4]thiadiazole-2-sulfonyl)-piperazin-1-yl] fluoroquinolonic derivatives. Eur J Med Chem. 2006;41(8):918–924.
   PubMed Web of Science ®Google Scholar
• Foroumadi A, Kargar Z, Sakhteman A, et al. Synthesis and antimycobacterial activity of some alkyl [5-(nitroaryl)-1,3,4-thiadiazol-2-ylthio]propionates. Bioorg Med Chem Lett. 2006;16(5):1164–1167.
   Web of Science ®Google Scholar
• More UA, Joshi SD, Aminabhavi TM, Gadad AK, Nadagouda MN, Kulkarni VH. Design, synthesis, molecular docking and 3D-QSAR studies of potent inhibitors of enoyl-acyl carrier protein reductase as potential antimycobacterial agents. Eur J Med Chem. 2014;71:199–218.
   PubMed Web of Science ®Google Scholar
• More UA, Joshi SD, Kulkarni VH. Antitubercular activity of pyrrole Schiff bases and computational study of M. tuberculosis InhA. Int J Drug Design Disc. 2013;4:1163–1173.
   Google Scholar
• Joshi SD, More UA, Aminabhavi TM, Badiger AM. Two- and three-dimensional QSAR studies on a set of antimycobacterial pyrroles: CoMFA, Topomer CoMFA, and HQSAR. Med Chem Res. 2014;23(1):107–126.
   Web of Science ®Google Scholar
• Joshi SD, More UA, Dixit SR, Korat HH, Aminabhavi TM, Badiger AM. Synthesis, characterization, biological activity, and 3D-QSAR studies on some novel class of pyrrole derivatives as antitubercular agents. Med Chem Res. 2014;23(3):1123–1147.
   Web of Science ®Google Scholar
• Joshi SD, Dixit SR, More UA, Devendra K, Aminabhavi TM, Kulkarni VH. 3D-QSAR studies of quinoline Schiff bases as enoyl acyl carrier protein reductase inhibitors. Res Rep Med Chem. 2014;4:59–75.
   Google Scholar
• Bukhari SN, Franzblau SG, Jantan I, Jasamai M. Current prospects of synthetic curcumin analogs and chalcone derivatives against Mycobacterium tuberculosis. Med Chem. 2013;9(7):897–903.
   Google Scholar
• Joshi SD, Joshi A, Vagdevi HM, Vaidya VP, Gadaginamath GS. Synthesis and antimicrobial evaluation of some new pyrrolylnaphtho[2,1-b] furan derivatives. Indian J Pharm Educ Res. 2010;44:148–155.
   Google Scholar
• Joshi SD, Joshi A, Vagdevi HM, Vaidya VP, Gadaginamath GS. Microwave assisted synthesis of some new quinolinylpyrrole derivatives as potential antibacterial and antitubercular agents. Indian J Heterocycl Chem. 2010;19:221–224.
   Web of Science ®Google Scholar
• Joshi SD, More Y, Vagdevi HM, Vaidya VP, Gadaginamath GS, Kulkarni VH. Synthesis of new 4-(2,5-dimethylpyrrol-1-yl)/4-pyrrol-1-yl benzoic acid hydrazide analogs and some derived oxadiazole, triazole and pyrrole ring systems a novel class of potential antibacterial, antifungal and antitubercular agents. Med Chem Res. 2013;22(3):1073–1089.
   Web of Science ®Google Scholar
• Joshi SD, Manish K, Badiger A. Synthesis and evaluation of antibacterial and antitubercular activities of some novel imidazo[2,1-b][1,3,4]thiadiazole derivatives. Med Chem Res. 2013;22(2):869–878.
   Web of Science ®Google Scholar
• Joshi SD, Vagdevi HM, Vaidya VP, Gadaginamath GS. Synthesis of new 4-pyrrol-1-yl benzoic acid hydrazide analogs and some derived oxadiazole, triazole and pyrrole ring systems,: a novel class of potential antibacterial and antitubercular agents. Eur J Med Chem. 2008;43(9):1989–1996.
   Web of Science ®Google Scholar
• Kitchen DB, Decornez H, Furr JR, Bajorath J. Docking and scoring in virtual screening for drug discovery: methods and applications. Nat Rev Drug Discov. 2004;3(11):935–949.
   PubMed Web of Science ®Google Scholar
• Ho CM, Marshall GR. Cavity search: an algorithm for the isolation and display of cavity-like binding regions. J Comput Aided Mol Des. 1990;4(4):337–354.
   Web of Science ®Google Scholar
• Jain AN. Scoring noncovalent protein-ligand interactions: a continuous differentiable function tuned to compute binding affinities. J Comput Aided Mol Des. 1996;10(5):427–440.
   PubMed Web of Science ®Google Scholar
• Jain AN. Surflex: fully automatic flexible molecular docking using a molecular similarity-based search engine. J Med Chem. 2003;46(4):499–511.
   PubMed Web of Science ®Google Scholar
• Tu G, Li S, Huang H, et al. Novel aminopeptidase N inhibitors derived from 1,3,4-thiadiazole scaffold. Bioorg Med Chem. 2008;16(14):6663–6668.
   PubMed Web of Science ®Google Scholar
• Franzblau SG, Witzig RS, McLaughlin JC, et al. Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay. J Clin Microbiol. 1998;36(2):362–366.
   PubMed Web of Science ®Google Scholar
• Clark M, Cramer RD III, Opdenbosch NV. Validation of the general purpose tripos 5.2 forcefield. J Comput Chem. 1989;10(8):982–1012.
   Web of Science ®Google Scholar
• Stewart JJ. ; StewartJJ. MOPAC: a semiempirical molecular orbital program. J Comput Aided Mol Des. 1990;4(1):1–105.
   PubMed Web of Science ®Google Scholar
• Spitzer R, Jain AN. Surflex-Dock: docking benchmarks and real-world application. J Comput Aided Mol Des. 2012;26(6):687–699.
   PubMed Web of Science ®Google Scholar
• Pham TA, Jain AN. Customizing scoring functions for docking. J Comput Aided Mol Des. 2008;22(5):269–286.
   Web of Science ®Google Scholar